Instil Bio
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|
Revenue | $0 | $3,986 | $0 |
Gross Profit | -498 | 1,993 | -900 |
EBITDA | -30,562 | -8,564 | -20,114 |
EBIT | -31,060 | -9,305 | -21,015 |
Net Income | -28,200 | -11,895 | -23,021 |
Net Change In Cash | 0 | 3,986 | 0 |
Free Cash Flow | -4,195 | -10,559 | -20,133 |
Cash | 15,366 | 8,805 | 6,663 |
Basic Shares | 6,532 | 6,525 | 6,506 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,610 | -4,756 | -5,987 | -2,752 |
EBITDA | -61,533 | -146,122 | -217,380 | -152,808 |
EBIT | -65,143 | -150,878 | -223,367 | -155,560 |
Net Income | -74,135 | -156,087 | -223,177 | -156,794 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -203,370 | |||
Free Cash Flow | -55,696 | -102,692 | -264,753 | -179,969 |
Cash | 8,805 | 9,195 | 43,716 | 37,590 |
Basic Shares | 6,510 | 6,503 | 6,475 | 5,299 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$2.88 |
2025-03-31 | -$1.32 |
2024-12-31 | -$1.08 |
2024-09-30 | -$2.55 |
